{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:37:55Z","timestamp":1790372275657,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.berh.2022.101776","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T05:00:14Z","timestamp":1663045214000},"page":"101776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Osteoporosis in children and young adults"],"prefix":"10.1016","volume":"36","author":[{"given":"Sophia D.","family":"Sakka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2022.101776_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J\u00a0Clin Densitom"},{"issue":"9","key":"10.1016\/j.berh.2022.101776_bib3","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique","volume":"8","author":"Genant","year":"1993","journal-title":"J\u00a0Bone Miner Res"},{"issue":"4","key":"10.1016\/j.berh.2022.101776_bib4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.jocd.2019.07.002","article-title":"The utility of DXA assessment at the forearm, proximal femur, and lateral distal femur, and vertebral fracture assessment in the pediatric population: 2019 ISCD official position","volume":"22","author":"Weber","year":"2019","journal-title":"J\u00a0Clin Densitom"},{"issue":"8","key":"10.1016\/j.berh.2022.101776_bib5","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1007\/s11547-012-0835-5","article-title":"Vertebral morphometry by dual-energy X-ray absorptiometry (DXA) for osteoporotic vertebral fractures assessment (VFA)","volume":"117","author":"Diacinti","year":"2012","journal-title":"Radiol Med"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib6","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1210\/jc.2009-2057","article-title":"Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children","volume":"95","author":"Zemel","year":"2010","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib7","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/jbmr.2935","article-title":"Amalgamated reference data for size-adjusted bone Densitometry measurements in 3598 children and young adults-the ALPHABET study","volume":"32","author":"Crabtree","year":"2017","journal-title":"J\u00a0Bone Miner Res"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib8","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jocd.2014.01.006","article-title":"Quantitative computer tomography in children and adolescents: the 2013 ISCD Pediatric Official Positions","volume":"17","author":"Adams","year":"2014","journal-title":"J\u00a0Clin Densitom"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib9","first-page":"61","article-title":"Childhood osteoporosis","volume":"6","author":"Khoshhal","year":"2011","journal-title":"J\u00a0T U Med Sc"},{"issue":"5","key":"10.1016\/j.berh.2022.101776_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s001980170112","article-title":"The burden of osteoporotic fractures: a method for setting intervention thresholds","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.berh.2022.101776_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11914-010-0031-2","article-title":"Biomechanics of vertebral fractures and the vertebral fracture cascade","volume":"8","author":"Christiansen","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/j.berh.2022.101776_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00223-012-9630-5","article-title":"Management of glucocorticoid-induced osteoporosis","volume":"91","author":"Rizzoli","year":"2012","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.berh.2022.101776_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jaci.2013.08.040","article-title":"Glucocorticoid-induced osteoporosis: an update on effects and management","volume":"132","author":"Buehring","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","article-title":"Glucocorticoid-induced osteoporosis: an update","volume":"61","author":"Compston","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/j.berh.2022.101776_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.semarthrit.2014.02.002","article-title":"A\u00a0systematic review and meta-analysis of glucocorticoid-induced osteoporosis in children","volume":"44","author":"Hansen","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib16","first-page":"664","article-title":"Glucocorticoids induce bone and muscle atrophy by tissue-specific mechanisms upstream of E3 ubiquitin ligases","volume":"158","author":"Sato","year":"2017","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ar.1092190104","article-title":"Bone \u201cmass\u201d and the \u201cmechanostat\u201d: a proposal","volume":"219","author":"Frost","year":"1987","journal-title":"Anat Rec"},{"key":"10.1016\/j.berh.2022.101776_bib18","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1469-8749.2011.04091.x","article-title":"Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review","volume":"54","author":"Fehlings","year":"2012","journal-title":"Dev Med Child Neurol"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr Osteoporos Rep"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib20","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S8756-3282(99)00162-3","article-title":"Interleukin-1 beta and tumor necrosis factor-alpha, but not interleukin-6, stimulate osteoprotegerin ligand gene expression in human osteoblastic cells","volume":"25","author":"Hofbauer","year":"1999","journal-title":"Bone"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib21","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bone.2006.02.074","article-title":"A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation","volume":"39","author":"Itoh","year":"2006","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.berh.2022.101776_bib22","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/BOR.0b013e328356b0c2","article-title":"Inflammatory diseases and bone health in children","volume":"24","author":"Burnham","year":"2012","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib23","doi-asserted-by":"crossref","first-page":"a031211","DOI":"10.1101\/cshperspect.a031211","article-title":"Regulation of bone metabolism by sex steroids","volume":"8","author":"Khosla","year":"2018","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.berh.2022.101776_bib24","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000381045","article-title":"Osteoporosis in children with chronic disease","volume":"28","author":"H\u00f6gler","year":"2015","journal-title":"Endocr Dev"},{"key":"10.1016\/j.berh.2022.101776_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bone.2016.12.004","article-title":"Hormonal and systemic regulation of sclerostin","volume":"96","author":"Drake","year":"2017","journal-title":"Bone"},{"key":"10.1016\/j.berh.2022.101776_bib26","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1359\/jbmr.1997.12.4.509","article-title":"From density to structure: growing up and growing old on the surfaces of bone","volume":"12","author":"Seeman","year":"1997","journal-title":"J\u00a0Bone Miner Res"},{"issue":"7","key":"10.1016\/j.berh.2022.101776_bib27","doi-asserted-by":"crossref","first-page":"E1272","DOI":"10.1210\/jc.2013-3887","article-title":"Associations of sex steroids with bone maturation, bone mineral density, bone geometry, and body composition: a cross-sectional study in healthy male adolescents","volume":"99","author":"Vandewalle","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib28","first-page":"44","article-title":"Mechanisms influencing bone metabolism in chronic illness","volume":"58","author":"Daci","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/j.berh.2022.101776_bib29","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1007\/s11999-010-1694-9","article-title":"Diseases affecting bone quality: beyond osteoporosis","volume":"469","author":"Unnanuntana","year":"2011","journal-title":"Clin Orthop Relat Res"},{"issue":"7","key":"10.1016\/j.berh.2022.101776_bib30","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S2213-8587(13)70180-3","article-title":"Endocrine consequences of anorexia nervosa","volume":"2","author":"Misra","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.berh.2022.101776_bib31","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.pediatrneurol.2006.03.004","article-title":"Adverse effects of antiepileptic drugs on bone mineral density","volume":"35","author":"Babayigit","year":"2006","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.berh.2022.101776_bib32","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"363","author":"Rauch","year":"2004","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib33","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J\u00a0Med Genet"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-016-0299-y","article-title":"Advances in the classification and treatment of osteogenesis imperfecta","volume":"14","author":"Thomas","year":"2016","journal-title":"Curr Osteoporos Rep"},{"issue":"12","key":"10.1016\/j.berh.2022.101776_bib35","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1007\/s00198-016-3723-3","article-title":"Osteogenesis imperfecta in children and adolescents\u2014new developments in diagnosis and treatment","volume":"27","author":"Trejo","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2022.101776_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000381037","article-title":"Primary osteoporosis","volume":"28","author":"Arundel","year":"2015","journal-title":"Endocr Dev"},{"issue":"5","key":"10.1016\/j.berh.2022.101776_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s00223-001-0045-y","article-title":"Idiopathic juvenile osteoporosis","volume":"70","author":"Lorenc","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.berh.2022.101776_bib38","series-title":"Ty he Cochrane database of systematic reviews","first-page":"CD010899","article-title":"Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy","volume":"1","author":"Bell","year":"2017"},{"issue":"4","key":"10.1016\/j.berh.2022.101776_bib39","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(18)30025-5","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management","volume":"17","author":"Birnkrant","year":"2018","journal-title":"Lancet Neurol"},{"issue":"6","key":"10.1016\/j.berh.2022.101776_bib40","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jamaneurol.2019.0242","article-title":"Fractures and linear growth in a nationwide cohort of boys with Duchenne muscular dystrophy with and without glucocorticoid treatment: results from the UK NorthStar Database","volume":"76","author":"Joseph","year":"2019","journal-title":"JAMA Neurol"},{"issue":"15","key":"10.1016\/j.berh.2022.101776_bib41","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1001\/jama.2022.4315","article-title":"Effect of different corticosteroid dosing regimens on clinical outcomes in boys with Duchenne muscular dystrophy: a randomized clinical trial","volume":"327","author":"Guglieri","year":"2022","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.44178","article-title":"Efficacy and safety of vamorolone in Duchenne muscular dystrophy: a 30-month non-randomised controlled open-label extension trial","volume":"5","author":"Mah","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.berh.2022.101776_bib43","series-title":"International conference of children\u2019s bone health (ICCBH)","article-title":"The prevalence and severity of vertebral fracture in children with various disorders treated with classic or dissociative steroids: a descriptive study of children enrolled in the STOPP and VPB15 (vamorolone) research program. Oral communication 17","author":"Jackowsky","year":"2022"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1053\/j.seminhematol.2013.06.007","article-title":"A\u00a050-year journey to cure childhood acute lymphoblastic leukemia","volume":"50","author":"Pui","year":"2013","journal-title":"Semin Hematol"},{"key":"10.1016\/j.berh.2022.101776_bib45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/BPB.0b013e32835d731c","article-title":"Musculoskeletal problems in pediatric acute leukemia","volume":"22","author":"Riccio","year":"2013","journal-title":"J\u00a0Pediatr Orthop B"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib46","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3109\/08880011003663382","article-title":"Childhood acute lymphoblastic leukemia (ALL) presenting with severe osteolysis: a model to study leukemia-bone interactions and potential targeted therapeutics","volume":"27","author":"Jayanthan","year":"2010","journal-title":"Pediatr Hematol Oncol"},{"issue":"7","key":"10.1016\/j.berh.2022.101776_bib47","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1359\/jbmr.090202","article-title":"Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program","volume":"24","author":"Halton","year":"2009","journal-title":"J\u00a0Bone Miner Res"},{"issue":"9","key":"10.1016\/j.berh.2022.101776_bib48","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1210\/JC.2015-2176","article-title":"Incident vertebral fractures in children with leukemia during the four years following diagnosis","volume":"100","author":"Cummings","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.berh.2022.101776_bib49","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/jbmr.3447","article-title":"Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Bone morbidity and recovery in children with acute lymphoblastic leukemia: results of a six-year prospective cohort study","volume":"33","author":"Ward","year":"2018","journal-title":"J\u00a0Bone Miner Res"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/acr.20589","article-title":"Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) Consortium. Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study","volume":"64","author":"Rodd","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"12","key":"10.1016\/j.berh.2022.101776_bib51","first-page":"e5195","article-title":"Osteoporotic fractures and vertebral body reshaping in children with glucocorticoid-treated rheumatic disorders","volume":"106","author":"Ward","year":"2021","journal-title":"JCEM"},{"key":"10.1016\/j.berh.2022.101776_bib52","first-page":"137","article-title":"Diseasemodifying antirheumatic drugs and bone mass in rheumatoid arthritis","volume":"23","author":"Di Munno","year":"2005","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.berh.2022.101776_bib53","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5435\/00124635-200708000-00002","article-title":"The effects of medications on bone","volume":"15","author":"Goodman","year":"2007","journal-title":"J\u00a0Am Acad Orthop Surg"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib54","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00431-013-2174-5","article-title":"Pathological fractures in paediatric patients with inflammatory bowel disease","volume":"173","author":"Wong","year":"2014","journal-title":"Eur J Pediatr"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib55","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/MPG.0b013e31821988a3","article-title":"Skeletal health of children and adolescents with inflammatory bowel disease","volume":"53","author":"Pappa","year":"2011","journal-title":"J\u00a0Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.berh.2022.101776_bib56","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1210\/jcem-73-3-555","article-title":"Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence","volume":"73","author":"Bonjour","year":"1991","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.berh.2022.101776_bib57","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1007\/s00198-017-4159-0","article-title":"Musculoskeletal health in newly diagnosed children with Crohn\u2019s disease","volume":"28","author":"Ward","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2022.101776_bib58","article-title":"Osteoporosis syndrome in thalassaemia major: an overview","author":"Toumba","year":"2010","journal-title":"J\u00a0Osteoporos"},{"key":"10.1016\/j.berh.2022.101776_bib59","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/MPH.0b013e3182841574","article-title":"Unrecognised vertebral fractures in adolescents and young adults with thalassemia syndromes","volume":"35","author":"Engakul","year":"2013","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.berh.2022.101776_bib60","doi-asserted-by":"crossref","unstructured":"Kyriakou A and Skordis N. Thalassemia, endocrine sequelae. Reference module in biomedical sciences. Elsevier doi:10.1016\/B978-0-12-801238-3.04488-3.","DOI":"10.1016\/B978-0-12-801238-3.04488-3"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib61","first-page":"167","article-title":"Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment","volume":"11","author":"De Sanctis","year":"2013","journal-title":"Pediatr Endocrinol Rev"},{"issue":"7","key":"10.1016\/j.berh.2022.101776_bib62","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/2192568218799074","article-title":"Review of sickle cell disease and spinal pathology","volume":"9","author":"Rudy","year":"2019","journal-title":"Global Spine J"},{"key":"10.1016\/j.berh.2022.101776_bib63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2141.2005.05476.x","article-title":"Bone involvement in sickle cell disease","volume":"129","author":"Almeida","year":"2005","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.berh.2022.101776_bib64","article-title":"The effects of treatment with blood transfusion, iron chelation and hydroxyurea on puberty, growth and spermatogenesis in sickle cell disease (SCD): a short update","volume":"92","author":"Soliman","year":"2021","journal-title":"Acta Biomed"},{"issue":"8","key":"10.1016\/j.berh.2022.101776_bib65","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/art.40137","article-title":"American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"69","author":"Buckley","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.berh.2022.101776_bib66","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1590\/S0482-50042012000400009","article-title":"Guidelines for the prevention and treatment of glucocorticoid induced osteoporosis","volume":"52","author":"Pereira","year":"2012","journal-title":"Rev Bras Reumatol"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib67","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global consensus recommendations on prevention and management of nutritional rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"1","key":"10.1016\/j.berh.2022.101776_bib68","first-page":"79","article-title":"Suit therapy versus whole-body vibrarion on bone mineral density in children with spastic diplegia","volume":"21","author":"El-Bagalaty","year":"2021","journal-title":"J\u00a0Musculoskelet Neuronal Interact"},{"issue":"2","key":"10.1016\/j.berh.2022.101776_bib69","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1080\/09593985.2019.1625089","article-title":"Effect of whole body vibration training on bone mineral density and functional capacity in children with thalassaemia","volume":"37","author":"Eid","year":"2021","journal-title":"Physiother Theory Pract"},{"issue":"8","key":"10.1016\/j.berh.2022.101776_bib70","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/jc.2017-00275","article-title":"The effect of whole body vibration training on bone and muscle function in children with osteogenesis imperfecta","volume":"102","author":"H\u00f6gler","year":"2017","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"12","key":"10.1016\/j.berh.2022.101776_bib71","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.cgh.2008.07.010","article-title":"Improvement in biomarkers of bone formation during infliximab therapy in pediatric Crohn\u2019s disease: results of the REACH study","volume":"6","author":"Thayu","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.berh.2022.101776_bib72","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/ibd.20069","article-title":"Linear growth improves during infliximab therapy in children with chronically active severe Crohn\u2019s disease","volume":"13","author":"Walters","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"7","key":"10.1016\/j.berh.2022.101776_bib73","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00198-016-3515-9","article-title":"The management of osteoporosis in children","volume":"27","author":"Ward","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.berh.2022.101776_bib74","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000365889","article-title":"The use of bisphosphonates in pediatrics","volume":"82","author":"Baroncelli","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/j.berh.2022.101776_bib75","first-page":"CD005324","article-title":"Bisphosphonate therapy for children and adolescents with secondary osteoporosis","author":"Ward","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.berh.2022.101776_bib76","first-page":"CD005088","article-title":"Bisphosphonate therapy for osteogenesis imperfecta","volume":"7","author":"Dwan","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1016\/j.berh.2022.101776_bib77","first-page":"e5222","article-title":"Zoledronic acid vs placebo in pediatric glucocorticoid-induced osteoporosis: a randomized, double-blind, phase 3 trial","volume":"106","author":"Ward","year":"2021","journal-title":"JCEM"},{"issue":"11","key":"10.1016\/j.berh.2022.101776_bib78","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1210\/jc.2015-2680","article-title":"Short-term safety of zoledronic acid in young patients with bone disorders: an extensive institutional experience","volume":"100","author":"George","year":"2015","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.berh.2022.101776_bib79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13023-014-0145-1","article-title":"Two years\u2019 experience with denosumab for children with osteogenesis imperfecta type VI","volume":"9","author":"Hoyer-Kuhn","year":"2014","journal-title":"Orphanet J Rare Dis"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694222000353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:24:42Z","timestamp":1761499482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694222000353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":78,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S1521694222000353"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2022.101776","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis in children and young adults","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2022.101776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101776"}}